Ineffective Azoles Against Mucor
Fluconazole and voriconazole lack meaningful in vitro activity against Mucorales and should never be used for treatment of mucormycosis. 1
Azoles Without Activity
The following azoles are ineffective against Mucor and other Mucorales:
Completely Ineffective Azoles
- Fluconazole has no meaningful in vitro activity against any Mucorales species and should be avoided entirely 1
- Voriconazole lacks meaningful activity against Mucorales in both in vitro and experimental animal models 1, 2, 1
Critical Clinical Caveat
There is concerning evidence that voriconazole prophylaxis or empirical therapy may paradoxically allow for longer patient survival, thereby increasing exposure time and risk for developing mucormycosis as a breakthrough infection. 2 This represents a dangerous clinical scenario where voriconazole successfully treats susceptible fungi (like Aspergillus) but leaves patients vulnerable to Mucorales.
Azoles With Limited or Variable Activity
Itraconazole
- Despite not being recommended for mucormycosis treatment, itraconazole demonstrates relatively low MICs for certain strains, particularly Rhizomucor and Lichtheimia species 1
- However, it is not recommended for clinical use in mucormycosis treatment 2
Isavuconazole
- Shows variable activity with MIC50 values of 1-4 mg/mL and MIC90 values of 4-16 mg/mL against Mucorales 2
- In vitro studies show MIC90 values over 8 mg/mL against 36 strains, which is significantly higher than posaconazole (MIC90 of 1-4 mg/mL) 2
- Clinical trial data (VITAL study) showed 33% day-42 mortality, similar to amphotericin B-treated controls 3
- Recent evidence suggests isavuconazole has species-dependent activity and may be considered as an alternative or salvage option 4, 3, 5
The Only Effective Azole
Posaconazole is the only azole with meaningful activity against Mucorales and is recommended as:
- Salvage therapy for patients refractory to or intolerant of amphotericin B 2, 6
- Prolonged continuation or maintenance therapy 2
- NOT as primary monotherapy 2
Posaconazole demonstrates the most consistent in vitro activity among azoles, with amphotericin B remaining the most active drug overall 1
Important Species-Specific Variations
The susceptibility of Mucorales to azoles varies significantly by genus and species:
- Amphotericin B yields lower MICs than posaconazole against Mucor circinelloides 1
- Posaconazole MICs are lower than amphotericin B against Cunninghamella bertholletiae 1
- Both agents show high MICs against Cunninghamella echinulata 1
- Significant strain-based variations exist, particularly for Rhizopus and Mucor species 1, 4